In the latest trading session,, 0.53 million Agenus Inc (NASDAQ:AGEN) shares changed hands as the company’s beta touched 1.44. With the company’s most recent per share price at $3.11 changing hands around $0.41 or 15.14% at last look, the market valuation stands at $78.68M. AGEN’s current price is a discount, trading about -533.12% off its 52-week high of $19.69. The share price had its 52-week low at $1.38, which suggests the last value was 55.63% up since then. When we look at Agenus Inc’s average trading volume, we note the 10-day average is 1.08 million shares, with the 3-month average coming to 529.31K.
Analysts gave the Agenus Inc (AGEN) stock a consensus recommendation rating of Hold, calculated at a mean rating of 2.50. If we narrow down to specifics, the data shows that 0 out of 2 analysts rate the stock as a Sell, with a further 0 assigning it an Overweight rating. Of the remaining, 2 recommended AGEN as a Hold, 0 felt it is a Buy and 0 rated the stock as Underweight. Agenus Inc’s EPS for the current quarter is expected to be -1.65.
Agenus Inc (NASDAQ:AGEN) trade information
Instantly AGEN is in green as seen in intraday trades today. With action 34.58%, the performance over the past five days has been green. The company’s shares are showing year-to-date upside of 13.46%, with the 5-day performance at 34.58% in the green. However, in the 30-day time frame, Agenus Inc (NASDAQ:AGEN) is 87.28% up. Looking at the short shares, we see there were 4.13 million shares sold at short interest cover period of 9.24 days.
The consensus price target for the stock as assigned by Wall Street analysts is 7, meaning bulls need an upside of 55.57% from its recent market value. According to analyst projections, AGEN’s forecast low is 7 with 7 as the target high. To hit the forecast high, the stock’s price needs a -125.08% plunge from its current level, while the stock would need to soar -125.08% for it to hit the projected low.
Agenus Inc (AGEN) estimates and forecasts
Year-over-year growth is forecast to reach 12.42% up from the last financial year.
Consensus estimates given by 4 financial analysts project the company’s revenue in the current quarter to hit an average of 21.98M. 4 analysts are of the opinion that Agenus Inc’s revenue for the current quarter will be 22.09M. The company’s revenue for the corresponding quarters a year ago was 28M and 23.51M respectively. According to analysts, the company will likely register a growth in its current quarter sales, forecast at -21.51%. The estimates for the next quarter sales put growth at -6.03%.
Looking at the company’s year-on-year earnings, data shows that the past 5-year has an earnings growth rate of 7.90%. The 2025 estimates are for Agenus Inc earnings to increase by 63.34%, but the outlook for the next 5-year period is at 33.07% per year.
AGEN Dividends
Agenus Inc is expected to release its next quarterly earnings report on 2025-Mar-10.
Agenus Inc (NASDAQ:AGEN)’s Major holders
If we look at who the major shareholders are, we find that insiders hold 1.39% of Agenus Inc shares while 33.76% of the shares are in the hands of institutional holders. The share float percentage for the stock currently stands at 34.24%. There are 33.76% institutions holding the Agenus Inc stock share, with VANGUARD GROUP INC the top institutional holder. As of 2024-06-30, the company held 10.2305% of the shares, roughly 2.15 million AGEN shares worth $36.09 million.
BLACKROCK INC. holds the second largest percentage of outstanding shares, with 7.3501% or 1.55 million shares worth $25.93 million as of 2024-06-30.
Among Mutual Funds, the top two as of Mar 31, 2025 were iShares Trust-iShares Russell 2000 ETF and VANGUARD INDEX FUNDS-Vanguard Total Stock Market Index Fund . With 674.91 shares estimated at $2.07 million under it, the former controlled 2.67% of total outstanding shares. On the other hand, VANGUARD INDEX FUNDS-Vanguard Total Stock Market Index Fund held about 2.59% of the shares, roughly 654.9 shares worth around $2.0 million.
